Robotic Flexible Ureteroscopy Versus Standard Flexible Ureteroscopy for Renal Stones
Launched by CHINESE UNIVERSITY OF HONG KONG · Oct 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two methods for treating kidney stones: robotic flexible ureteroscopy and standard flexible ureteroscopy. Both procedures involve using a thin tube with a camera to remove stones from the kidneys, but one method uses robotic technology to assist the doctor. The goal of the study is to see which method is more effective and has better outcomes for patients.
To participate in this trial, you need to be at least 18 years old and able to give your consent. However, there are some criteria that might exclude you, such as having certain urinary tract problems, a high level of health issues that could complicate anesthesia, or having untreated infections. If you're interested in joining the study, you'll receive detailed information about the procedures and what to expect during your treatment, helping you make an informed decision about your care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years old with informed consent
- • Being willing and able to provide written informed consent
- Exclusion Criteria:
- • Patients with abnormal urinary tract (e.g. ileal conduit, neobladder, ureteric stricture)
- • American Society of Anesthesiologists (ASA) physical status classification system \>3
- • Untreated urinary tract infection
- • Renal stones \> 3cm in diameter
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheung Shui, , Hong Kong
Patients applied
Trial Officials
Chi Fai NG, MD
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported